Bladder Cancer BCG Administration Proves Effective After Recurrence In Bladder-preserving Therapy For MIBC Aug 29, 2023
Bladder Cancer CG0070 Combined With Pembrolizumab In BCG-unresponsive NMIBC Pts: PD13-08 CORE1 Study Results Aug 25, 2023
Bladder Cancer,Genitourinary Cancer HCRS as a Risk Assessment Tool to Identify Pts Needing Further Investigations Aug 07, 2023
Bladder Cancer,Genitourinary Cancer,Other Cancers The Efficacy of Prophylactic Biologic Mesh on the PSH Development in Ileal Conduit Aug 03, 2023
Bladder Cancer,Genitourinary Cancer,Other Cancers NAP as an Effective Systemic Therapy Prior to Radical Cystectomy for Cisplatin-Ineligible MIBC Aug 02, 2023
Bladder Cancer,Genitourinary Cancer,Other Cancers Initial Findings of SunRISE-1 in High-Risk Non-Muscle-Invasive Bladder Cancer Jul 28, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Pembrolizumab Plus Lenvatinib as First-Line Treatment for nCRCC Jun 02, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Cabozantinib Plus Nivolumab Shows Promise in Non-clear-Cell Renal Cell Carcinoma May 30, 2023
